National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Patisiran
Synonyms

RNAi Therapeutic-targeting Transthyretin ALN-TTR02

ALN-18328

ALN-TTR02

PATISIRAN

Patisiran

Definitions

A lipid nanoparticle (LNP)-based formulation consisting of small-interfering RNAs (siRNAs) directed against transthyretin (TTR) encapsulated in lipids, which has potential use in the treatment of TTR-mediated amyloidosis (ATTR). Upon intravenous administration of patisiran, the lipid formulation promotes the uptake by cells. The siRNAs bind to TTR mRNAs, which may result in the inhibition of both the translation and expression of the TTR protein. ATTR is caused by mutations in the TTR gene and results in the formation of abnormal amyloid proteins that accumulate in and cause damage to various body organs and tissues.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116792

CAS_Registry

1420706-45-1

code

C116792

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

DEFINITION

A lipid nanoparticle (LNP)-based formulation consisting of small-interfering RNAs (siRNAs) directed against transthyretin (TTR) encapsulated in lipids, which has potential use in the treatment of TTR-mediated amyloidosis (ATTR). Upon intravenous administration of patisiran, the lipid formulation promotes the uptake by cells. The siRNAs bind to TTR mRNAs, which may result in the inhibition of both the translation and expression of the TTR protein. ATTR is caused by mutations in the TTR gene and results in the formation of abnormal amyloid proteins that accumulate in and cause damage to various body organs and tissues.

FDA_UNII_Code

50FKX8CB2Y

FULL_SYN

RNAi Therapeutic-targeting Transthyretin ALN-TTR02

ALN-18328

ALN-TTR02

PATISIRAN

Patisiran

label

Patisiran

NCI_Drug_Dictionary_ID

762821

PDQ_Closed_Trial_Search_ID

762821

PDQ_Open_Trial_Search_ID

762821

Preferred_Name

Patisiran

prefixIRI

Thesaurus:C116792

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C3896714

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C129821

Delete Subject Author Type Created
No notes to display